Therefore, these results suggest that miR-22-3p regulates the expression of several targets that can control the cell cycle and that galectin-1 regulates the cell cycle in hormone receptor-positive breast cancer and inhibits cancer progression. This evidence concerns the gene LGALS1 and cancer.